Net profit of Aspira Pathlab & Diagnostics rose 85.86% to Rs 1.84 crore in the quarter ended September 2025 as against Rs 0.99 crore during the previous quarter ended September 2024. Sales rose 30.91% to Rs 8.09 crore in the quarter ended September 2025 as against Rs 6.18 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales8.096.18 31 OPM %27.1921.84 - PBDT2.241.35 66 PBT1.840.99 86 NP1.840.99 86 Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics announced that the 52th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live News

Net profit of Aspira Pathlab & Diagnostics rose 740.00% to Rs 0.42 crore in the quarter ended June 2025 as against Rs 0.05 crore during the previous quarter ended June 2024. Sales rose 13.15% to Rs 5.25 crore in the quarter ended June 2025 as against Rs 4.64 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales5.254.64 13 OPM %12.955.60 - PBDT0.790.42 88 PBT0.420.05 740 NP0.420.05 740 Powered by Capital Market - Live News

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live News